Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the Lilly Medical website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical

  1. Medical Information Right
  2. Diabetes Right
  3. Mounjaro (tirzepatide) injection Right
  4. Can adults taking tirzepatide receive a COVID-19 vaccine?
Search Mounjaro (tirzepatide) injection (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Mounjaro ® (tirzepatide) injection

2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg

Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Can adults taking tirzepatide receive a COVID-19 vaccine?

The use of the COVID-19 vaccine in adults treated with tirzepatide has not been studied.

US_cFAQ_TZP395_CONSUMER_COVID_VACCINES
US_cFAQ_TZP395_CONSUMER_COVID_VACCINES
en-US

See important safety information, including boxed warning, in the attached prescribing information.

Use With COVID-19 Vaccines

Eli Lilly and Company (Lilly) has not studied the use of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in patients treated with tirzepatide.

Please speak with your healthcare provider about whether you should get a COVID-19 vaccine.

For additional questions regarding your treatment with tirzepatide and a COVID-19 vaccine, contact your health care provider. For current information and updates on a potential COVID-19 vaccine, please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html. 

SARS-CoV-2 is the virus that has caused the COVID-19 pandemic. Vaccines against SARS-CoV-2 are available.1

Enclosed Prescribing Information

MOUNJARO™ (tirzepatide) injection, for subcutaneous use, Lilly

Reference

1COVID-19 vaccines. World Health Organization (WHO). Accessed November 9, 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines

Date of Last Review: May 25, 2022

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Consumer Health Privacy Notice
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.43 4/2025 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2025. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    California Consumer Privacy Act (CCPA) Opt-Out Icon Your Privacy Choices
    Cookie Settings
    facebook twitter linkedin
    visit www.phactmi.org
    Lilly